Literature DB >> 11525348

Helminths, human immunodeficiency virus and tuberculosis.

G Borkow1, Z Weisman, Q Leng, M Stein, A Kalinkovich, D Wolday, Z Bentwich.   

Abstract

Helminth infections affect over a quarter of the world's population, especially in the developing countries. These long-lasting parasitic infections cause widespread immune activation and dysregulation, a dominant Th2 cytokine immune profile and an immune hyporesponsiveness state. Considering these profound immune changes and the similar geographic distributions of helminthic infections, HIV and tuberculosis (TB), we suggest that helminthic infections play a major role in the pathogenesis of AIDS and TB. They apparently make the host more susceptible to infection by HIV and Mycobacterium tuberculosis, and impair his/her ability to generate protective immunity against both infections. The implication of these ideas is that without eradication of helminth infections and/or modulation of the immune changes that they cause, HIV and TB vaccines may fail to confer protection against their respective infections in helminth-endemic areas.

Entities:  

Mesh:

Year:  2001        PMID: 11525348     DOI: 10.1080/00365540110026656

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  29 in total

Review 1.  Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Impairment of protective immunity to blood-stage malaria by concurrent nematode infection.

Authors:  Zhong Su; Mariela Segura; Kenneth Morgan; J Concepcion Loredo-Osti; Mary M Stevenson
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice.

Authors:  D Elias; H Akuffo; C Thors; A Pawlowski; S Britton
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

Review 4.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 5.  Regulation of type 1 diabetes, tuberculosis, and asthma by parasites.

Authors:  Zhugong Liu; Qian Liu; David Bleich; Padmini Salgame; William C Gause
Journal:  J Mol Med (Berl)       Date:  2009-10-21       Impact factor: 4.599

6.  Serum IgE levels of tuberculosis patients in a tropical setup with high prevalence of HIV and intestinal parasitoses.

Authors:  A Kassu; A Mohammad; Y Fujimaki; F Moges; D Elias; F Mekonnen; G Mengistu; M Yamato; Y Wondmikun; F Ota
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

7.  Reduced protective efficacy of a blood-stage malaria vaccine by concurrent nematode infection.

Authors:  Zhong Su; Mariela Segura; Mary M Stevenson
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

8.  Purification and molecular cloning of and immunization with Ancylostoma ceylanicum excretory-secretory protein 2, an immunoreactive protein produced by adult hookworms.

Authors:  Richard D Bungiro; Carolina V Solis; Lisa M Harrison; Michael Cappello
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

Review 9.  Do antenatal parasite infections devalue childhood vaccination?

Authors:  A Desiree Labeaud; Indu Malhotra; Maria J King; Christopher L King; Charles H King
Journal:  PLoS Negl Trop Dis       Date:  2009-05-26

10.  Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance.

Authors:  Damalie Nakanjako; Agnes Kiragga; Fowzia Ibrahim; Barbara Castelnuovo; Moses R Kamya; Philippa J Easterbrook
Journal:  AIDS Res Ther       Date:  2008-10-28       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.